US8586781B2
(en)
*
|
1998-04-02 |
2013-11-19 |
Mbc Pharma, Inc. |
Bone targeted therapeutics and methods of making and using the same
|
ES2319732T3
(es)
|
2000-04-13 |
2009-05-12 |
Pharmasset, Inc. |
Derivados de nucleosido 3'- o 2'-hidroximetilo sustituido para el tratamiento de infecciones virales.
|
MY164523A
(en)
*
|
2000-05-23 |
2017-12-29 |
Univ Degli Studi Cagliari |
Methods and compositions for treating hepatitis c virus
|
WO2001092282A2
(en)
*
|
2000-05-26 |
2001-12-06 |
Idenix (Cayman) Limited |
Methods and compositions for treating flaviviruses and pestiviruses
|
WO2003026589A2
(en)
*
|
2001-09-28 |
2003-04-03 |
Idenix (Cayman) Limited |
Methods and compositions for treating hepatitis c virus using 4'-modified nucleosides
|
US7285658B2
(en)
*
|
2002-02-28 |
2007-10-23 |
Biota, Inc. |
Nucleotide mimics and their prodrugs
|
US7608600B2
(en)
*
|
2002-06-28 |
2009-10-27 |
Idenix Pharmaceuticals, Inc. |
Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
|
KR20050035194A
(ko)
*
|
2002-06-28 |
2005-04-15 |
이데닉스 (케이만) 리미티드 |
플라비비리다에 감염 치료용 2'-c-메틸-3'-o-l-발린에스테르 리보푸라노실 사이티딘
|
CN101172993A
(zh)
*
|
2002-06-28 |
2008-05-07 |
埃迪尼克斯(开曼)有限公司 |
用于治疗黄病毒感染的2′-c-甲基-3′-o-l-缬氨酸酯核糖呋喃基胞苷
|
BR0313164A
(pt)
|
2002-08-01 |
2007-07-17 |
Pharmasset Inc |
compostos com o sistema biciclo[4.2.1] nonano para o tratamento de infecções por flaviviridae
|
DE10238722A1
(de)
|
2002-08-23 |
2004-03-11 |
Bayer Ag |
Selektive Phosphodiesterase 9A-Inhibitoren als Arzneimittel zur Verbesserung kognitiver Prozesse
|
US7094768B2
(en)
|
2002-09-30 |
2006-08-22 |
Genelabs Technologies, Inc. |
Nucleoside derivatives for treating hepatitis C virus infection
|
KR20050088079A
(ko)
*
|
2002-11-15 |
2005-09-01 |
이데닉스 (케이만) 리미티드 |
2'-분지형 뉴클레오시드 및 플라비비리다에 돌연변이
|
CA2509687C
(en)
*
|
2002-12-12 |
2012-08-14 |
Idenix (Cayman) Limited |
Process for the production of 2'-branched nucleosides
|
WO2004058792A1
(en)
*
|
2002-12-23 |
2004-07-15 |
Idenix (Cayman) Limited |
Process for the production of 3'-nucleoside prodrugs
|
US7550442B2
(en)
*
|
2003-05-20 |
2009-06-23 |
The Board Of Trustees Of The University Of Illinois |
Nucleoside analog inhibitors of reverse transcriptase
|
LT2604620T
(lt)
*
|
2003-05-30 |
2016-09-12 |
Gilead Pharmasset Llc |
Modifikuoti fluorintų nukleozidų analogai
|
KR20060084845A
(ko)
|
2003-07-25 |
2006-07-25 |
이데닉스 (케이만) 리미티드 |
C형 간염을 포함하는 플라비비리다에를 치료하기 위한퓨린 뉴클레오시드 유사체
|
CN101023094B
(zh)
*
|
2004-07-21 |
2011-05-18 |
法莫赛特股份有限公司 |
烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
|
ITFI20040173A1
(it)
*
|
2004-08-03 |
2004-11-03 |
Protera S R L |
Profarmaci attivati da dna polimerasi dipendenti da rna
|
CA2580457C
(en)
|
2004-09-14 |
2014-11-04 |
Pharmasset, Inc. |
Preparation of 2'fluoro-2'-alkyl-substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives
|
BRPI0515896A
(pt)
*
|
2004-09-24 |
2008-08-12 |
Idenix Cayman Ltd E Ct Nat De |
composto ou um sal ou éster farmaceuticamente aceitável do mesmo, método para o tratamento ou profilaxia de um hospedeiro infectado com uma infecção por flavivìrus, pestivìrus ou hepacivìrus, e, composição farmacêutica para o tratamento de um hospedeiro infectado com uma infecção por flavivìrus, pestivìrus ou hepacivìrus
|
RU2322450C2
(ru)
*
|
2004-11-25 |
2008-04-20 |
Закрытое акционерное общество "Производственно-коммерческая Ассоциация АЗТ" |
Модифицированные 5'-фосфонаты азт в качестве активных компонентов для потенциальных противовирусных препаратов
|
JP2008532950A
(ja)
|
2005-03-08 |
2008-08-21 |
バイオタ サイエンティフィック マネージメント ピーティーワイ リミテッド |
治療薬としての二環式ヌクレオシドおよび二環式ヌクレオチド
|
WO2006101911A1
(en)
|
2005-03-16 |
2006-09-28 |
Case Western Reserve University |
Selective inhibitors of translesion dna replication
|
WO2008147454A1
(en)
*
|
2006-11-16 |
2008-12-04 |
Case Western Reserve University |
Selective inhibitors of translesion dna replication
|
CA2665370A1
(en)
*
|
2005-10-03 |
2007-04-12 |
University Health Network |
Odcase inhibitors for the treatment of malaria
|
AU2006298677A1
(en)
*
|
2005-10-06 |
2007-04-12 |
Innate Pharma |
Phosphoantigen salts of organic bases and methods for their crystallization
|
WO2007075876A2
(en)
*
|
2005-12-23 |
2007-07-05 |
Idenix Pharmaceuticals, Inc. |
Process for preparing a synthetic intermediate for preparation of branched nucleosides
|
WO2008005542A2
(en)
|
2006-07-07 |
2008-01-10 |
Gilead Sciences, Inc., |
Antiviral phosphinate compounds
|
EP3342415B1
(en)
|
2006-08-08 |
2022-01-26 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
Structure and use of 5' phosphate oligonucleotides
|
US20080261913A1
(en)
|
2006-12-28 |
2008-10-23 |
Idenix Pharmaceuticals, Inc. |
Compounds and pharmaceutical compositions for the treatment of liver disorders
|
US8324179B2
(en)
*
|
2007-02-09 |
2012-12-04 |
Gilead Sciences, Inc. |
Nucleoside analogs for antiviral treatment
|
US8618074B2
(en)
*
|
2007-03-15 |
2013-12-31 |
Board Of Regents Of The University Of Texas System |
GPCR enhanced neuroprotection to treat brain injury
|
US7964580B2
(en)
|
2007-03-30 |
2011-06-21 |
Pharmasset, Inc. |
Nucleoside phosphoramidate prodrugs
|
EP2164500B1
(en)
*
|
2007-05-25 |
2013-12-04 |
Idogen AB |
The use of zeburaline for the treatment of autoimmune diseases or immune rejection of transplants
|
EP2574616A3
(en)
*
|
2007-08-02 |
2013-09-04 |
Southern Research Institute |
5'-substituted adenosynes, preparation thereof and use as inhibitors of s-adenosylmethionine decarboxylase.
|
EP2207787B1
(en)
|
2007-11-06 |
2014-11-12 |
AdiuTide Pharmaceuticals GmbH |
Immune stimulatory oligoribonucleotide analogs containing modified oligophosphate moieties
|
PE20091211A1
(es)
|
2007-11-30 |
2009-09-14 |
Boehringer Ingelheim Int |
Derivados de pirazolopirimidina como moduladores de pde9a
|
WO2009116044A2
(en)
*
|
2008-03-19 |
2009-09-24 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Compounds for treating bacterial infections
|
UA105362C2
(en)
|
2008-04-02 |
2014-05-12 |
Бьорингер Ингельхайм Интернациональ Гмбх |
1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators
|
EP2268642B1
(en)
|
2008-04-23 |
2015-02-25 |
Gilead Sciences, Inc. |
1' -substituted carba-nucleoside analogs for antiviral treatment
|
JP5689413B2
(ja)
|
2008-05-21 |
2015-03-25 |
ライニッシュ フリードリッヒ−ウィルヘルムズ−ユニバーシタット ボン |
平滑末端を有する5’三リン酸オリゴヌクレオチドおよびその使用
|
US8173621B2
(en)
*
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
WO2010002877A2
(en)
|
2008-07-03 |
2010-01-07 |
Biota Scientific Management |
Bycyclic nucleosides and nucleotides as therapeutic agents
|
KR20110063447A
(ko)
|
2008-09-08 |
2011-06-10 |
베링거 인겔하임 인터내셔날 게엠베하 |
피라졸로피리미딘 및 cns 장애의 치료를 위한 이들의 용도
|
WO2010028781A1
(en)
*
|
2008-09-10 |
2010-03-18 |
Universität Zürich |
8- and 6,8-substituted-2'-deoxyguanosines and uses thereof
|
ES2616051T3
(es)
|
2008-12-02 |
2017-06-09 |
Wave Life Sciences Japan, Inc. |
Método para la síntesis de ácidos nucleicos modificados en el átomo de fósforo
|
WO2010075554A1
(en)
|
2008-12-23 |
2010-07-01 |
Pharmasset, Inc. |
Synthesis of purine nucleosides
|
JP5713919B2
(ja)
|
2008-12-23 |
2015-05-07 |
ギリアド ファーマセット エルエルシー |
ヌクレオシドホスホラミデート
|
PA8855701A1
(es)
|
2008-12-23 |
2010-07-27 |
|
Análogos de nucleósidos
|
GEP20146098B
(en)
|
2009-03-31 |
2014-05-27 |
Boehringer Ingelheim Int |
1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their usage as pde9a modulators
|
US8618076B2
(en)
|
2009-05-20 |
2013-12-31 |
Gilead Pharmasset Llc |
Nucleoside phosphoramidates
|
TWI598358B
(zh)
|
2009-05-20 |
2017-09-11 |
基利法瑪席特有限責任公司 |
核苷磷醯胺
|
AU2010270714B2
(en)
|
2009-07-06 |
2015-08-13 |
Wave Life Sciences Ltd. |
Novel nucleic acid prodrugs and methods use thereof
|
PT2480559E
(pt)
|
2009-09-21 |
2013-10-02 |
Gilead Sciences Inc |
Processos e intermediários para a preparação de análogos de 1'-ciano-carbanucleósido
|
EP2752422B1
(en)
|
2010-03-31 |
2017-08-16 |
Gilead Pharmasset LLC |
Stereoselective synthesis of phosphorus containing actives
|
PL3290428T3
(pl)
|
2010-03-31 |
2022-02-07 |
Gilead Pharmasset Llc |
Tabletka zawierająca krystaliczny (S)-2-(((S)-(((2R,3R,4R,5R)-5-(2,4-diokso-3,4-dihydropirymidyn-1(2H)-ylo)-4-fluoro-3-hydroksy-4-metylotetrahydrofuran-2-ylo)metoksy)(fenoksy)fosforylo)amino)propanian izopropylu
|
WO2011139695A2
(en)
|
2010-04-28 |
2011-11-10 |
Isis Pharmaceuticals, Inc. |
Modified 5' diphosphate nucleosides and oligomeric compounds prepared therefrom
|
KR20200052384A
(ko)
|
2010-07-19 |
2020-05-14 |
길리애드 사이언시즈, 인코포레이티드 |
부분입체 이성질성으로 순수한 포스포라미데이트 전구약물의 제조 방법
|
ME01924B
(me)
|
2010-07-22 |
2015-05-20 |
Gilead Sciences Inc |
Metode i jedinjenja za lečenje infekcija izazvanih Paramyxoviridae virusom
|
MX344770B
(es)
|
2010-08-12 |
2017-01-06 |
Boehringer Ingelheim Int Gmbh * |
Derivados de 6-cicloalquil-1,5-dihidro-pirazolo (3,4-d) pirimidin-4-onas y su uso como inhibidores de pde9a.
|
WO2012034719A1
(en)
*
|
2010-09-14 |
2012-03-22 |
Centre National De La Recherche Scientifique |
Novel antiviral acyclic nucleoside phosphonates
|
SG188497A1
(en)
|
2010-09-22 |
2013-05-31 |
Alios Biopharma Inc |
Substituted nucleotide analogs
|
US10428019B2
(en)
|
2010-09-24 |
2019-10-01 |
Wave Life Sciences Ltd. |
Chiral auxiliaries
|
TW201242974A
(en)
|
2010-11-30 |
2012-11-01 |
Gilead Pharmasset Llc |
Compounds
|
US8809345B2
(en)
|
2011-02-15 |
2014-08-19 |
Boehringer Ingelheim International Gmbh |
6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders
|
EP2508530A1
(en)
|
2011-03-28 |
2012-10-10 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
Purification of triphosphorylated oligonucleotides using capture tags
|
US9243025B2
(en)
|
2011-03-31 |
2016-01-26 |
Idenix Pharmaceuticals, Llc |
Compounds and pharmaceutical compositions for the treatment of viral infections
|
EA201391519A1
(ru)
|
2011-04-13 |
2014-03-31 |
Мерк Шарп И Доум Корп. |
2'-замещенные нуклеозидные производные и способы их применения для лечения вирусных заболеваний
|
EP2697242B1
(en)
|
2011-04-13 |
2018-10-03 |
Merck Sharp & Dohme Corp. |
2'-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
CA2832449A1
(en)
|
2011-04-13 |
2012-10-18 |
Vinay GIRIJAVALLABHAN |
2'-cyano substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
WO2012166645A1
(en)
*
|
2011-06-01 |
2012-12-06 |
Syndax Pharmaceuticals, Inc. |
Prodrugs of azacitidine 5' -diphosphate
|
WO2013009735A1
(en)
*
|
2011-07-13 |
2013-01-17 |
Merck Sharp & Dohme Corp. |
5'-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
US9408863B2
(en)
|
2011-07-13 |
2016-08-09 |
Merck Sharp & Dohme Corp. |
5′-substituted nucleoside analogs and methods of use thereof for the treatment of viral diseases
|
EP2734208B1
(en)
|
2011-07-19 |
2017-03-01 |
Wave Life Sciences Ltd. |
Methods for the synthesis of functionalized nucleic acids
|
US9334300B2
(en)
|
2011-08-01 |
2016-05-10 |
Mbc Pharma, Inc. |
Vitamin B6 derivatives of nucleotides, acyclonucleotides and acyclonucleoside phosphonates
|
US9988680B2
(en)
|
2011-09-01 |
2018-06-05 |
Case Western Reserve University |
Non-natural nucleosides as theranostic agents
|
EP2755983B1
(en)
*
|
2011-09-12 |
2017-03-15 |
Idenix Pharmaceuticals LLC. |
Substituted carbonyloxymethylphosphoramidate compounds and pharmaceutical compositions for the treatment of viral infections
|
LT2709613T
(lt)
|
2011-09-16 |
2018-02-12 |
Gilead Pharmasset Llc |
Žmogaus hepatito viruso (hcv) gydymo būdai
|
WO2013056046A1
(en)
|
2011-10-14 |
2013-04-18 |
Idenix Pharmaceuticals, Inc. |
Substituted 3',5'-cyclic phosphates of purine nucleotide compounds and pharmaceutical compositions for the treatment of viral infections
|
US8889159B2
(en)
|
2011-11-29 |
2014-11-18 |
Gilead Pharmasset Llc |
Compositions and methods for treating hepatitis C virus
|
EP2794630A4
(en)
|
2011-12-22 |
2015-04-01 |
Alios Biopharma Inc |
SUBSTITUTED PHOSPHORTHIOAT NUCLEOTIDE ANALOGUE
|
US8916538B2
(en)
|
2012-03-21 |
2014-12-23 |
Vertex Pharmaceuticals Incorporated |
Solid forms of a thiophosphoramidate nucleotide prodrug
|
ME03502B
(me)
*
|
2012-03-21 |
2020-04-20 |
Janssen Biopharma Inc |
Supstituisani nukleozidi, nukleotidi i njihovi analozi
|
WO2013142157A1
(en)
|
2012-03-22 |
2013-09-26 |
Alios Biopharma, Inc. |
Pharmaceutical combinations comprising a thionucleotide analog
|
AU2013266393B2
(en)
|
2012-05-22 |
2017-09-28 |
Idenix Pharmaceuticals Llc |
D-amino acid compounds for liver disease
|
CN107011400B
(zh)
|
2012-07-13 |
2021-05-25 |
波涛生命科学有限公司 |
不对称辅助基团
|
EP2712870A1
(en)
|
2012-09-27 |
2014-04-02 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
Novel RIG-I ligands and methods for producing them
|
US10513534B2
(en)
|
2012-10-08 |
2019-12-24 |
Idenix Pharmaceuticals Llc |
2′-chloro nucleoside analogs for HCV infection
|
PE20151778A1
(es)
|
2013-01-31 |
2015-12-16 |
Gilead Pharmasset Llc |
Formulacion combinada de dos compuestos antivirales
|
US9821173B2
(en)
*
|
2013-02-08 |
2017-11-21 |
Case Western Reserve University |
Anti-cancer agents and methods of use
|
WO2014137926A1
(en)
|
2013-03-04 |
2014-09-12 |
Idenix Pharmaceuticals, Inc. |
3'-deoxy nucleosides for the treatment of hcv
|
WO2014160484A1
(en)
|
2013-03-13 |
2014-10-02 |
Idenix Pharmaceuticals, Inc. |
Amino acid phosphoramidate pronucleotides of 2'-cyano, azido and amino nucleosides for the treatment of hcv
|
WO2014160200A1
(en)
|
2013-03-13 |
2014-10-02 |
Dana-Farber Cancer Institute, Inc. |
Ras inhibitors and uses thereof
|
US10005779B2
(en)
|
2013-06-05 |
2018-06-26 |
Idenix Pharmaceuticals Llc |
1′,4′-thio nucleosides for the treatment of HCV
|
US20150037282A1
(en)
|
2013-08-01 |
2015-02-05 |
Idenix Pharmaceuticals, Inc. |
D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver disease
|
SI3038601T1
(sl)
|
2013-08-27 |
2020-07-31 |
Gilead Pharmasset Llc |
Formulacija kombinacije dveh protivirusnih spojin
|
CN103772247B
(zh)
*
|
2014-01-06 |
2016-06-08 |
苏州汉酶生物技术有限公司 |
一种可用于合成辛伐他汀铵盐的酰基供体的制备方法
|
KR102423317B1
(ko)
|
2014-01-16 |
2022-07-22 |
웨이브 라이프 사이언시스 리미티드 |
키랄 디자인
|
CN103788140A
(zh)
*
|
2014-01-26 |
2014-05-14 |
江西科技师范大学 |
核苷5′-β,γ亚甲基及双卤代亚甲基三磷酸合成方法
|
WO2015161137A1
(en)
|
2014-04-16 |
2015-10-22 |
Idenix Pharmaceuticals, Inc. |
3'-substituted methyl or alkynyl nucleosides for the treatment of hcv
|
CZ309218B6
(cs)
*
|
2014-08-26 |
2022-06-01 |
Univerzita Palackého v Olomouci |
Způsob stanovení aktivity enzymů přeměňujících cytosinové deriváty na uracilové deriváty v buňkách a tkáních
|
TWI698444B
(zh)
|
2014-10-29 |
2020-07-11 |
美商基利科學股份有限公司 |
製備核糖苷的方法
|
UA124966C2
(uk)
|
2015-03-06 |
2021-12-22 |
Атеа Фармасеутікалс, Інк. |
<font face="Symbol">b</font>-D-2'-ДЕЗОКСИ-2'-<font face="Symbol">a</font>-ФТОР-2'-<font face="Symbol">b</font>-C-ЗАМІЩЕНІ-2-МОДИФІКОВАНІ-N<sup>6</sup>-ЗАМІЩЕНІ ПУРИНОВІ НУКЛЕОТИДИ ДЛЯ ЛІКУВАННЯ ВИКЛИКАНИХ HCV ЗАХВОРЮВАНЬ
|
EP3349758B1
(en)
|
2015-09-16 |
2022-04-06 |
Gilead Sciences, Inc. |
Methods for treating arenaviridae virus infections
|
WO2017087837A1
(en)
|
2015-11-20 |
2017-05-26 |
Forma Therapeutics, Inc. |
Purinones as ubiquitin-specific protease 1 inhibitors
|
LU100724B1
(en)
|
2016-07-14 |
2018-07-31 |
Atea Pharmaceuticals Inc |
Beta-d-2'-deoxy-2'-alpha-fluoro-2'-beta-c-substituted-4'-fluoro-n6-substituted-6-amino-2-substituted purine nucleotides for the treatment of hepatitis c virus infection
|
WO2018048937A1
(en)
|
2016-09-07 |
2018-03-15 |
Atea Pharmaceuticals, Inc. |
2'-substituted-n6-substituted purine nucleotides for rna virus treatment
|
EP3555293A4
(en)
|
2016-12-15 |
2020-08-12 |
Meharry Medical College |
ANTIVIRAL AGENTS
|
SG11201906163TA
(en)
|
2017-02-01 |
2019-08-27 |
Atea Pharmaceuticals Inc |
Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus
|
KR102460968B1
(ko)
|
2017-03-14 |
2022-11-01 |
길리애드 사이언시즈, 인코포레이티드 |
고양이 코로나바이러스 감염의 치료 방법
|
CA3059777C
(en)
|
2017-05-01 |
2023-02-21 |
Gilead Sciences, Inc. |
Crystalline forms of (s)-2-ethylbutyl 2-(((s)-(((2r,3s,4r,5r)-5-(4-aminopyrrolo[2,1-f] [1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy) phosphoryl)amino)propanoate
|
EP3651734A1
(en)
|
2017-07-11 |
2020-05-20 |
Gilead Sciences, Inc. |
Compositions comprising an rna polymerase inhibitor and cyclodextrin for treating viral infections
|
KR20200140865A
(ko)
|
2018-04-10 |
2020-12-16 |
아테아 파마슈티컬즈, 인크. |
간경변증을 갖는 hcv 감염 환자의 치료
|
KR20210102364A
(ko)
|
2018-12-12 |
2021-08-19 |
얀센 바이오파마, 인코퍼레이트. |
항바이러스제로서의 사이클로펜틸 뉴클레오시드 유사체
|
JP2022522534A
(ja)
|
2019-04-02 |
2022-04-19 |
アリゴス セラピューティクス インコーポレイテッド |
Prmt5を標的にする化合物
|
WO2021113627A1
(en)
|
2019-12-06 |
2021-06-10 |
Vertex Pharmaceuticals Incorporated |
Substituted tetrahydrofurans as modulators of sodium channels
|
JP2023512656A
(ja)
|
2020-01-27 |
2023-03-28 |
ギリアード サイエンシーズ, インコーポレイテッド |
SARS CoV-2感染を治療するための方法
|
US10874687B1
(en)
|
2020-02-27 |
2020-12-29 |
Atea Pharmaceuticals, Inc. |
Highly active compounds against COVID-19
|
US11613553B2
(en)
|
2020-03-12 |
2023-03-28 |
Gilead Sciences, Inc. |
Methods of preparing 1′-cyano nucleosides
|
EP4132651A1
(en)
|
2020-04-06 |
2023-02-15 |
Gilead Sciences, Inc. |
Inhalation formulations of 1'-cyano substituted carbanucleoside analogs
|
TW202203941A
(zh)
|
2020-05-29 |
2022-02-01 |
美商基利科學股份有限公司 |
瑞德西韋之治療方法
|
US11939347B2
(en)
|
2020-06-24 |
2024-03-26 |
Gilead Sciences, Inc. |
1′-cyano nucleoside analogs and uses thereof
|
MX2023002195A
(es)
|
2020-08-27 |
2023-03-03 |
Gilead Sciences Inc |
Compuestos y metodos para el tratamiento de infecciones virales.
|
TW202313593A
(zh)
|
2021-06-04 |
2023-04-01 |
美商維泰克斯製藥公司 |
作為鈉通道調節劑之n—(羥基烷基(雜)芳基)四氫呋喃甲醯胺
|
US20230295172A1
(en)
|
2022-03-02 |
2023-09-21 |
Gilead Sciences, Inc. |
Compounds and methods for treatment of viral infections
|